Cargando…
Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ?
Although SARS-CoV-2 is considered a lung-tropic virus, severe COVID-19 is not just a viral pulmonary infection, clinically it is a multi-organ pathology with major coagulation abnormalities and thromboembolism events. Recently, antiphospholipid (aPL) antibodies were found increased in a large number...
Autores principales: | Devaux, Christian A., Camoin-Jau, Laurence, Mege, Jean-Louis, Raoult, Didier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783458/ https://www.ncbi.nlm.nih.gov/pubmed/33500211 http://dx.doi.org/10.1016/j.jmii.2020.12.010 |
Ejemplares similares
-
ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome
por: Devaux, Christian A., et al.
Publicado: (2020) -
An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection
por: Devaux, Christian A., et al.
Publicado: (2022) -
Molecular Mimicry of the Viral Spike in the SARS-CoV-2 Vaccine Possibly Triggers Transient Dysregulation of ACE2, Leading to Vascular and Coagulation Dysfunction Similar to SARS-CoV-2 Infection
por: Devaux, Christian A., et al.
Publicado: (2023) -
Hydroxychloroquine is protective to the heart, not harmful: a systematic review
por: Prodromos, C.C., et al.
Publicado: (2020) -
Thrombotic microangiopathy: COVID-19 or hydroxychloroquine?
por: Hasbal, Nuri Baris
Publicado: (2020)